BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35413424)

  • 1. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
    Li X; Chen W; Huang L; Zhu M; Zhang H; Si Y; Li H; Luo Q; Yu B
    Pharmacol Res; 2022 May; 179():106222. PubMed ID: 35413424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
    Tang W; Li M; Qi X; Li J
    Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
    Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
    Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
    Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
    FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
    Li Y; Wu C
    IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-205/RunX2 axis negatively regulates CD44
    Zhang L; Liu L; Xu X; He X; Wang G; Fan C; Zheng Q; Li F
    Am J Cancer Res; 2020; 10(6):1871-1887. PubMed ID: 32642297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
    Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
    Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.
    Li X; Li P; Liu C; Ren Y; Tang X; Wang K; He J
    Oncotarget; 2017 Feb; 8(8):13560-13574. PubMed ID: 28088791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
    Chopra S; Goel S; Thakur B; Bhatia A
    Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.